Scott Garland, PACT Pharma CEO

PACT Phar­ma sus­pends sole clin­i­cal tri­al

Ed­i­tor’s note: Fol­low­ing ad­di­tion­al ed­i­to­r­i­al re­view, this ar­ti­cle and head­line have been cor­rect­ed to re­flect that the 51 af­fect­ed em­ploy­ees high­light­ed in the Cal­i­for­nia WARN …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.